Adma Biologics (ADMA) Interest Coverage Ratio (2011 - 2025)
Adma Biologics (ADMA) posted Interest Coverage Ratio of 8.74 for Q4 2025, down 19.25% on a QoQ basis from 10.83 in Q3 2025, and up 108.74% year-over-year from 4.19 in Q4 2024.
Adma Biologics (ADMA) Interest Coverage Ratio (2011 - 2025) Analysis & Trends
Adma Biologics' Interest Coverage Ratio history runs 13 years deep, the most recent figure standing at 8.74 for Q4 2025.
- Quarterly Interest Coverage Ratio rose 108.74% year-over-year to 8.74 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 13.6 (up 4.39% YoY) and the FY2025 annual result came in at 4.86, up 138.25% from the prior year.
- Interest Coverage Ratio was 8.74 for Q4 2025 at Adma Biologics, down from 10.83 in the prior quarter.
- Across five years, Interest Coverage Ratio topped out at 11.33 in Q3 2024 and bottomed at 100.06 in Q4 2024.
- A 5-year average of 3.31 and a median of 0.31 in 2022 frame the typical range for Interest Coverage Ratio.
- Peak annual rise in Interest Coverage Ratio reached 13899.75% in 2024, while the deepest fall reached 11437.87% in 2024.
- Adma Biologics' Interest Coverage Ratio stood at 1.1 in 2021, then jumped by 56.35% to 0.48 in 2022, then plunged by 80.07% to 0.87 in 2023, then sank by 11437.87% to 100.06 in 2024, then surged by 108.74% to 8.74 in 2025.
- Business Quant data shows ADMA's Interest Coverage Ratio at 8.74 in Q4 2025, 10.83 in Q3 2025, and 2.78 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | Adma Biologics | 1.99 Bn | 1.91 Bn | 88.82 Mn | 8.74 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 8.74 |
| Sep 30, 2025 | 10.83 |
| Jun 30, 2025 | 2.78 |
| Mar 31, 2025 | 7.32 |
| Dec 31, 2024 | -100.06 |
| Sep 30, 2024 | 11.33 |
| Jun 30, 2024 | 10.36 |
| Mar 31, 2024 | 5.79 |
| Dec 31, 2023 | -0.87 |
| Sep 30, 2023 | 1.36 |
| Jun 30, 2023 | -0.08 |
| Mar 31, 2023 | -0.13 |
| Dec 31, 2022 | -0.48 |
| Sep 30, 2022 | -1.67 |
| Jun 30, 2022 | -2.01 |
| Mar 31, 2022 | -4.37 |
| Dec 31, 2021 | -1.10 |
| Sep 30, 2021 | -4.38 |
| Jun 30, 2021 | -4.80 |
| Mar 31, 2021 | -4.75 |